These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 23861811)
1. Wnt pathway activity in breast cancer sub-types and stem-like cells. Lamb R; Ablett MP; Spence K; Landberg G; Sims AH; Clarke RB PLoS One; 2013; 8(7):e67811. PubMed ID: 23861811 [TBL] [Abstract][Full Text] [Related]
2. New generation breast cancer cell lines developed from patient-derived xenografts. Finlay-Schultz J; Jacobsen BM; Riley D; Paul KV; Turner S; Ferreira-Gonzalez A; Harrell JC; Kabos P; Sartorius CA Breast Cancer Res; 2020 Jun; 22(1):68. PubMed ID: 32576280 [TBL] [Abstract][Full Text] [Related]
3. Self-renewal of CD133(hi) cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer. Sansone P; Ceccarelli C; Berishaj M; Chang Q; Rajasekhar VK; Perna F; Bowman RL; Vidone M; Daly L; Nnoli J; Santini D; Taffurelli M; Shih NN; Feldman M; Mao JJ; Colameco C; Chen J; DeMichele A; Fabbri N; Healey JH; Cricca M; Gasparre G; Lyden D; Bonafé M; Bromberg J Nat Commun; 2016 Feb; 7():10442. PubMed ID: 26858125 [TBL] [Abstract][Full Text] [Related]
4. Identification of new cancer stem cell markers and signaling pathways in HER‑2‑positive breast cancer by transcriptome sequencing. Feng L; Huang S; An G; Wang G; Gu S; Zhao X Int J Oncol; 2019 Nov; 55(5):1003-1018. PubMed ID: 31545416 [TBL] [Abstract][Full Text] [Related]
5. Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer. Puvirajesinghe TM; Bertucci F; Jain A; Scerbo P; Belotti E; Audebert S; Sebbagh M; Lopez M; Brech A; Finetti P; Charafe-Jauffret E; Chaffanet M; Castellano R; Restouin A; Marchetto S; Collette Y; Gonçalvès A; Macara I; Birnbaum D; Kodjabachian L; Johansen T; Borg JP Nat Commun; 2016 Jan; 7():10318. PubMed ID: 26754771 [TBL] [Abstract][Full Text] [Related]
6. Focal adhesion kinase and Wnt signaling regulate human ductal carcinoma in situ stem cell activity and response to radiotherapy. Williams KE; Bundred NJ; Landberg G; Clarke RB; Farnie G Stem Cells; 2015 Feb; 33(2):327-41. PubMed ID: 25187396 [TBL] [Abstract][Full Text] [Related]
7. WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines. Sikora MJ; Jacobsen BM; Levine K; Chen J; Davidson NE; Lee AV; Alexander CM; Oesterreich S Breast Cancer Res; 2016 Sep; 18(1):92. PubMed ID: 27650553 [TBL] [Abstract][Full Text] [Related]
8. ESR1 Fusions Invoke Breast Cancer Subtype-Dependent Enrichment of Ligand-Independent Oncogenic Signatures and Phenotypes. Yates ME; Waltermire H; Mori K; Li Z; Li Y; Guzolik H; Wang X; Liu T; Atkinson JM; Hooda J; Lee AV; Oesterreich S Endocrinology; 2024 Aug; 165(10):. PubMed ID: 39207954 [TBL] [Abstract][Full Text] [Related]
9. Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines. Tong D; Schuster E; Seifert M; Czerwenka K; Leodolte S; Zeillinger R Breast Cancer Res Treat; 2002 Feb; 71(3):249-55. PubMed ID: 12002343 [TBL] [Abstract][Full Text] [Related]
10. Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer. Kok M; Koornstra RH; Margarido TC; Fles R; Armstrong NJ; Linn SC; Van't Veer LJ; Weigelt B J Pathol; 2009 Jul; 218(3):316-26. PubMed ID: 19353633 [TBL] [Abstract][Full Text] [Related]
11. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype. Habashy HO; Powe DG; Glaab E; Ball G; Spiteri I; Krasnogor N; Garibaldi JM; Rakha EA; Green AR; Caldas C; Ellis IO Breast Cancer Res Treat; 2011 Jul; 128(2):315-26. PubMed ID: 20697807 [TBL] [Abstract][Full Text] [Related]
12. Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC. Iwase T; Harano K; Masuda H; Kida K; Hess KR; Wang Y; Dirix L; Van Laere SJ; Lucci A; Krishnamurthy S; Woodward WA; Layman RM; Bertucci F; Ueno NT BMC Cancer; 2020 May; 20(1):430. PubMed ID: 32423453 [TBL] [Abstract][Full Text] [Related]
13. The Role of Breast Cancer Stem Cells and Some Related Molecular Biomarkers in Metastatic and Nonmetastatic Breast Cancer. El Abbass KA; Abdellateif MS; Gawish AM; Zekri AN; Malash I; Bahnassy AA Clin Breast Cancer; 2020 Aug; 20(4):e373-e384. PubMed ID: 32299754 [TBL] [Abstract][Full Text] [Related]
14. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439 [TBL] [Abstract][Full Text] [Related]
15. Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation. Sun Y; Wang Y; Fan C; Gao P; Wang X; Wei G; Wei J Mol Cancer; 2014 Jun; 13():137. PubMed ID: 24889938 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer. Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698 [TBL] [Abstract][Full Text] [Related]
17. PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness. Wang X; Jung YS; Jun S; Lee S; Wang W; Schneider A; Sun Oh Y; Lin SH; Park BJ; Chen J; Keyomarsi K; Park JI Nat Commun; 2016 Feb; 7():10633. PubMed ID: 26843124 [TBL] [Abstract][Full Text] [Related]
18. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer. Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288 [TBL] [Abstract][Full Text] [Related]
19. Anti-cancer stem cell activity of a hedgehog inhibitor GANT61 in estrogen receptor-positive breast cancer cells. Kurebayashi J; Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T Cancer Sci; 2017 May; 108(5):918-930. PubMed ID: 28211214 [TBL] [Abstract][Full Text] [Related]
20. Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases. Bu G; Lu W; Liu CC; Selander K; Yoneda T; Hall C; Keller ET; Li Y Int J Cancer; 2008 Sep; 123(5):1034-42. PubMed ID: 18546262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]